about
Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-betaSilica, Silicosis, and AutoimmunityIntracellular nucleic acid sensors and autoimmunityRelationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patientsAnti-IFN-γ and peptide-tolerization therapies inhibit acute lung injury induced by cross-reactive influenza A-specific memory T cellsInterferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsEpithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.Recognition of interferon-inducible sites, promoters, and enhancers.Arthritis suppression by NADPH activation operates through an interferon-beta pathwayTLRs and IFNs: critical pieces of the autoimmunity puzzleType I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Cytokines regulate complement receptor immunoglobulin expression and phagocytosis of Candida albicans in human macrophages: A control point in anti-microbial immunity.Ethyl Caffeate Ameliorates Collagen-Induced Arthritis by Suppressing Th1 Immune Response.Systemic lupus erythematosus and increased risk to develop B cell malignancies: role of the p200-family proteins.IFNαR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFN-dependent inflammatory disease.Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.Treatment of neuromyelitis optica: current debate.Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritisSuppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS productionIFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.The dysregulation of cytokine networks in systemic lupus erythematosus.Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?Sensors of the innate immune system: their link to rheumatic diseases.An immune competent mouse model for the characterization of recombinant measles vaccines.Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.The role of Toll-like receptors in immune disorders.Therapeutic targeting of the inflammome.Anti-IFN-α/β receptor antibody treatment ameliorates disease in lupus-predisposed miceRNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profilesDeath receptor 5 mediated-apoptosis contributes to cholestatic liver disease.Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.Molecular mechanisms of the anti-inflammatory functions of interferonsOsteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific AntibodiesIn Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity.Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus.Interferon-alpha in the management of patients with Behçet's disease.Cytokines in Sjögren's syndrome.
P2860
Q21260407-259DE21A-B412-41D3-B087-AAEE11ED79DFQ26751007-EDA7B5CF-EFEF-4C53-85F8-D13A717CA679Q26997316-421D9BFC-A2BF-4ABD-8E66-DC94800EF95CQ28290930-69E7E489-6065-4C10-8F1B-7CC69F3B0D25Q30427198-FBC1584F-4865-473C-9783-F60DEAC9F66DQ30499869-77336235-0E6C-4338-96C5-43640E1F2B26Q33232149-067C94B3-5375-4A21-8394-D78CE5C76BA5Q33274587-85720DE0-28EA-42DD-BC10-1C0F301BFFBFQ33284147-9C371258-6CA9-4919-B864-FB0A5AD73712Q33354714-19F78CDA-C5CE-4978-853C-2949AD44F0CDQ33569835-5EE68EF1-D576-49CE-AD74-764CB7E2345CQ33659118-A61DCA5B-35DE-4D69-BCBA-E77D9EE74C81Q33825976-0F6C59DB-B4CB-46BC-AEC4-F64ED266B3F0Q33863687-5709D7C8-D15D-4153-8308-391F7444C073Q34079465-0BEEB4DF-039A-4569-8A03-D202A7D86D6AQ34146449-47571681-DEEC-4248-A9A7-9FE00657E05AQ34218597-F4004477-43DE-4938-8E8E-37B85E9BBD8AQ34409070-9010D0A7-C393-4F40-BE38-046928EC2F69Q34450615-EE749F16-A72C-4A7B-B7C1-2871F2B7A343Q34538178-79DE35AE-57AB-4DE1-80DD-04589883C682Q34544423-87D41FFB-1754-423E-A0C7-AACFF89A4343Q35082666-91A5AA57-569E-4D45-ABF8-B737739329B4Q35294513-F5A5A40C-DC96-41A3-93F3-437D670671BCQ35575081-69640F9E-A5A9-48E6-8547-05AC0AF4B11BQ35623130-B7DBBCFC-B111-4B8A-9A2E-2BD5576A351BQ35887095-EEA3C12F-117D-4B2A-87EC-6295EC5130A9Q35901700-30CCD6EA-D77D-4FFD-9089-D8E30740B104Q36407231-B13CC942-CB7B-4906-9F8F-D88B080B97D8Q36490256-5E62C1E2-8541-4414-AEA3-78CBBEBF3D51Q36490737-4F97913F-7802-4E73-A8F1-901E03F0A8E4Q36787367-AE531E4D-4818-496C-92C9-B3979C768947Q36825315-A53EC8F0-E210-4837-A5E9-B770604EFCF2Q36960285-B2DDE13C-73FE-48E0-A079-A76FAE49AB93Q37034582-2A8DC06F-345E-4195-AC55-25B96C3CECDCQ37050067-9B5C532E-E50E-4842-B18C-7F4FF38C7389Q37052024-44C4C784-8A4F-40A3-8410-EA97984FC127Q37212570-634F5260-E6CB-4172-B328-487E29816D90Q37298794-23FE9F49-9C47-4FAA-B4AC-545E2A7545A4Q37307804-D434AC50-8F9C-41BD-80EA-1406B3033FD7Q37387713-DE535131-ABE3-46E3-A49C-2019F34779E3
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interferons as pathogenic effectors in autoimmunity.
@ast
Interferons as pathogenic effectors in autoimmunity.
@en
type
label
Interferons as pathogenic effectors in autoimmunity.
@ast
Interferons as pathogenic effectors in autoimmunity.
@en
prefLabel
Interferons as pathogenic effectors in autoimmunity.
@ast
Interferons as pathogenic effectors in autoimmunity.
@en
P2093
P2860
P1476
Interferons as pathogenic effectors in autoimmunity.
@en
P2093
Argyrios N Theofilopoulos
Dwight H Kono
Roberto Baccala
P2860
P356
10.1111/J.0105-2896.2005.00252.X
P577
2005-04-01T00:00:00Z